Ken W. Marshall

Insider Reports History

Entity
Individual
Location
30 Technology Drive, Warren, NJ
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ken W. Marshall:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. SVP, Chief Commercial Officer Performance Stock Units 75K Aug 9, 2023 Direct

Insider Reports Filed by Ken W. Marshall

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AQST Aquestive Therapeutics, Inc. Aug 9, 2023 1 $0 4 Aug 9, 2023 SVP, Chief Commercial Officer
AQST Aquestive Therapeutics, Inc. May 5, 2023 1 $0 4 May 5, 2023 SVP, Chief Commercial Officer
AQST Aquestive Therapeutics, Inc. Mar 9, 2023 1 $0 4 Mar 9, 2023 SVP, Chief Commercial Officer
AQST Aquestive Therapeutics, Inc. Nov 4, 2022 1 $0 4 Nov 8, 2022 SVP, Chief Commercial Officer
AQST Aquestive Therapeutics, Inc. Mar 10, 2022 1 $0 4 Mar 14, 2022 SVP, Chief Commercial Officer